All News #Library
Biotech
Numab Hits Milestone with Boehringer Ingelheim
18 Dec 2025 //
GLOBENEWSWIRE
Numab Achieves Milestone in Collaboration with Boehringer
25 Sep 2025 //
GLOBENEWSWIRE
Numab Therapeutics Appoints Angehrn Pavik as New CEO
09 Sep 2025 //
GLOBENEWSWIRE
Numab Therapeutics Announces Series C Extension to CHF 180 Million
09 Jan 2025 //
GLOBENEWSWIRE
Biotechs behind J&J-bought Yellow Jersey partner on IBD drug
15 Nov 2024 //
FIERCE BIOTECH
Numab, Kaken Partner on ND081 for Inflammatory Bowel Disease
15 Nov 2024 //
GLOBENEWSWIRE
J&J: Rights To Atopic Dermatitis Bispecific Antibody Candidate
28 May 2024 //
BUSINESSWIRE

Market Place
Sourcing Support